Retinal blood flow abnormalities following six months of hyperglycemia in the Ins2(Akita) mouse

Experimental Eye Research

Volumn 98, Issue 1, 2012, Pages 9-15

  Wright, William S ^a,b   Singh Yadav, Amit ^a   McElhatten, Robert M ^a   Harris, Norman R ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF SOUTH CAROLINA UPSTATE   (United States)

Author keywords

Blood flow; Diabetes; Hypoxia; Mouse; Retina

Indexed keywords

PIMONIDAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FLOW VELOCITY; BLOOD VESSEL DIAMETER; CONTROLLED STUDY; ERYTHROCYTE; HYPERGLYCEMIA; HYPOXIA; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MICROSCOPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETINA BLOOD FLOW; RETINA BLOOD VESSEL; RETINA ISCHEMIA; SHEAR STRESS; TISSUE OXYGENATION;

ANIMALS; ANOXIA; BLOOD CELL COUNT; BLOOD FLOW VELOCITY; BLOOD GLUCOSE; CAPILLARIES; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; DISEASE MODELS, ANIMAL; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HYPERGLYCEMIA; MALE; MICE; MICE, INBRED C57BL; OXYGEN; OXYGEN CONSUMPTION; REGIONAL BLOOD FLOW; RETINAL VESSELS;

EID: 84860228244     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2012.03.003     Document Type: Article

References (50)

1. Ayalasomayajula S.P., Kompella U.B. Celecoxib, a selective cyclooxygenase-2 inhibitor, inhibits retinal vascular endothelial growth factor expression and vascular leakage in a streptozotocin-induced diabetic rat model. Eur. J. Pharmacol. 2003, 458:283-289.
2. Barber A.J., Antonetti D.A., Kern T.S., Reiter C.E., Soans R.S., Krady J.K., Levison S.W., Gardner T.W., Bronson S.K. The Ins2Akita mouse as a model of early retinal complications in diabetes. Invest. Ophthalmol. Vis. Sci. 2005, 46:2210-2218.
3. Barber A.J., Gardner T.W., Abcouwer S.F. The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 2011, 52:1156-1163.
4. Barouch F.C., Miyamoto K., Allport J.R., Fujita K., Bursell S.E., Aiello L.P., Luscinskas F.W., Adamis A.P. Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes. Invest. Ophthalmol. Vis. Sci. 2000, 41:1153-1158.
5. Basu R., Oudit G.Y., Wang X., Zhang L., Ussher J.R., Lopaschuk G.D., Kassiri Z. Type 1 diabetic cardiomyopathy in the Akita (Ins2WT/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic function. Am. J. Physiol. Heart. Circ. Physiol. 2009, 297:H2096-H2108.
6. Berkowitz B.A., Roberts R. Prognostic MRI biomarkers of treatment efficacy for retinopathy. NMR. Biomed. 2008, 21:957-967.
7. Chen P., Scicli G.M., Guo M., Fenstermacher J.D., Dahl D., Edwards P.A., Scicli A.G. Role of angiotensin II in retinal leukostasis in the diabetic rat. Exp. Eye. Res. 2006, 83:1041-1051.
8. Clermont A.C., Aiello L.P., Mori F., Aiello L.M., Bursell S.E. Vascular endothelial growth factor and severity of nonproliferative diabetic retinopathy mediate retinal hemodynamics in vivo: a potential role for vascular endothelial growth factor in the progression of nonproliferative diabetic retinopathy. Am. J. Ophthalmol. 1997, 124:433-446.
9. Curtis T.M., Gardiner T.A., Stitt A.W. Microvascular lesions of diabetic retinopathy: clues towards understanding pathogenesis?. Eye. (Lond.) 2009, 23:1496-1508.
10. de Gooyer T.E., Stevenson K.A., Humphries P., Simpson D.A., Gardiner T.A., Stitt A.W. Retinopathy is reduced during experimental diabetes in a mouse model of outer retinal degeneration. Invest. Ophthalmol. Vis. Sci. 2006, 47:5561-5568.
11. Durham J.T., Herman I.M. Microvascular modifications in diabetic retinopathy. Curr. Diab. Rep. 2011, 11:253-264.
12. Faulhaber-Walter R., Chen L., Oppermann M., Kim S.M., Huang Y., Hiramatsu N., Mizel D., Kajiyama H., Zerfas P., Briggs J.P., Kopp J.B., Schnermann J. Lack of A1 adenosine receptors augments diabetic hyperfiltration and glomerular injury. J. Am. Soc. Nephrol. 2008, 19:722-730.
13. Fong D.S., Aiello L., Gardner T.W., King G.L., Blankenship G., Cavallerano J.D., Ferris F.L., Klein R. Diabetic retinopathy. Diabetes. Care. 2003, 26:226-229.
14. Hammes H.P., Feng Y., Pfister F., Brownlee M. Diabetic retinopathy: targeting vasoregression. Diabetes 2011, 60:9-16.
15. Holekamp N.M., Shui Y.B., Beebe D. Lower intraocular oxygen tension in diabetic patients: possible contribution to decreased incidence of nuclear sclerotic cataract. Am. J. Ophthalmol. 2006, 141:1027-1032.
16. Illing E.K., Gray C.H. Retinal metabolism in diabetes; the metabolism of retinae of normal and alloxandiabetic rabbits. J. Endocrinol. 1951, 7:242-247.
17. Kleiter M.M., Thrall D.E., Malarkey D.E., Ji X., Lee D.Y., Chou S.C., Raleigh J.A. A comparison of oral and intravenous pimonidazole in canine tumors using intravenous CCI-103F as a control hypoxia marker. Int. J. Radiat. Oncol. Biol. Phys. 2006, 64:592-602.
18. Koch C.J. Importance of antibody concentration in the assessment of cellular hypoxia by flow cytometry: EF5 and pimonidazole. Radiat. Res. 2008, 169:677-688.
19. Konno S., Feke G.T., Yoshida A., Fujio N., Goger D.G., Buzney S.M. Retinal blood flow changes in type I diabetes. A long-term follow-up study. Invest. Ophthalmol. Vis. Sci. 1996, 37:1140-1148.
20. Kowluru R.A., Jirousek M.R., Stramm L., Farid N., Engerman R.L., Kern T.S. Abnormalities of retinal metabolism in diabetes or experimental galactosemia: V. Relationship between protein kinase C and ATPases. Diabetes 1998, 47:464-469.
21. Lau J.C., Linsenmeier R.A. Oxygen consumption and distribution in the diabetic rat retina. Invest. Ophthalmol. Vis. Sci. 2010, 51. E-abstract 5644.
22. Leal E.C., Manivannan A., Hosoya K., Terasaki T., Cunha-Vaz J., Ambrosio A.F., Forrester J.V. Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 2007, 48:5257-5265.
23. Lee S., Harris N.R. Losartan and ozagrel reverse retinal arteriolar constriction in non-obese diabetic mice. Microcirculation 2008, 15:379-387.
24. Lee S., Morgan G.A., Harris N.R. Ozagrel reverses streptozotocin-induced constriction of arterioles in rat retina. Microvasc. Res. 2008, 76:217-223.
25. Linsenmeier R.A., Braun R.D., McRipley M.A., Padnick L.B., Ahmed J., Hatchell D.L., McLeod D.S., Lutty G.A. Retinal hypoxia in long-term diabetic cats. Invest. Ophthalmol. Vis. Sci. 1998, 39:1647-1657.
26. Martin P.M., Roon P., Van Ells T.K., Ganapathy V., Smith S.B. Death of retinal neurons in streptozotocin-induced diabetic mice. Invest. Ophthalmol. Vis. Sci. 2004, 45:3330-3336.
27. Miyamoto K., Khosrof S., Bursell S.E., Rohan R., Murata T., Clermont A.C., Aiello L.P., Ogura Y., Adamis A.P. Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. Proc. Natl. Acad. Sci. U S A 1999, 96:10836-10841.
28. Moon J.W., Kim Y.J., Khwarg S.I., Chung H., Yu H.G. Chorioretinal ischemia and angiogenic milieu following photodynamic therapy. Curr. Eye. Res. 2010, 35:314-321.
29. Mowat F.M., Luhmann U.F., Smith A.J., Lange C., Duran Y., Harten S., Shukla D., Maxwell P.H., Ali R.R., Bainbridge J.W. HIF-1alpha and HIF-2alpha are differentially activated in distinct cell populations in retinal ischaemia. PLoS One 2010, 5:e11103.
30. Ottlecz A., Bensaoula T. Captopril ameliorates the decreased Na+, K(+)-ATPase activity in the retina of streptozotocin-induced diabetic rats. Invest. Ophthalmol. Vis. Sci. 1996, 37:1633-1641.
31. Park J.W., Park S.J., Park S.H., Kim K.Y., Chung J.W., Chun M.H., Oh S.J. Up-regulated expression of neuronal nitric oxide synthase in experimental diabetic retina. Neurobiol. Dis. 2006, 21:43-49.
32. Pe'er J., Folberg R., Itin A., Gnessin H., Hemo I., Keshet E. Upregulated expression of vascular endothelial growth factor in proliferative diabetic retinopathy. Br. J. Ophthalmol. 1996, 80:241-245.
33. Pournaras C.J. Retinal oxygen distribution. Its role in the physiopathology of vasoproliferative microangiopathies. Retina 1995, 15:332-347.
34. Raleigh J.A., Koch C.J. Importance of thiols in the reductive binding of 2-nitroimidazoles to macromolecules. Biochem. Pharmacol. 1990, 40:2457-2464.
35. Rimmer T., Linsenmeier R.A. Resistance of diabetic rat electroretinogram to hypoxemia. Invest. Ophthalmol. Vis. Sci. 1993, 34:3246-3252.
36. Rossing P. The changing epidemiology of diabetic microangiopathy in type 1 diabetes. Diabetologia 2005, 48:1439-1444.
37. Small K.W., Stefansson E., Hatchell D.L. Retinal blood flow in normal and diabetic dogs. Invest. Ophthalmol. Vis. Sci. 1987, 28:672-675.
38. Sutherland F.S., Stefansson E., Hatchell D.L., Reiser H. Retinal oxygen consumption in vitro. The effect of diabetes mellitus, oxygen and glucose. Acta. Ophthalmol. (Copenh.) 1990, 68:715-720.
39. Wang Z., Yadav A.S., Leskova W., Harris N.R. Attenuation of streptozotocin-induced microvascular changes in the mouse retina with the endothelin receptor A antagonist atrasentan. Exp. Eye. Res. 2010, 91:670-675.
40. Wang Z., Yadav A.S., Leskova W., Harris N.R. Inhibition of 20-HETE attenuates diabetes-induced decreases in retinal hemodynamics. Exp. Eye. Res. 2011, 93:108-113.
41. Wright W.S., Harris N.R. Ozagrel attenuates early streptozotocin-induced constriction of arterioles in the mouse retina. Exp. Eye. Res. 2008, 86:528-536.
42. Wright W.S., Messina J.E., Harris N.R. Attenuation of diabetes-induced retinal vasoconstriction by a thromboxane receptor antagonist. Exp. Eye. Res. 2009, 88:106-112.
43. Wright W.S., McElhatten R.M., Messina J.E., Harris N.R. Hypoxia and the expression of HIF-1alpha and HIF-2alpha in the retina of streptozotocin-injected mice and rats. Exp. Eye. Res. 2010, 90:405-412.
44. Wright W.S., McElhatten R.M., Harris N.R. Increase in retinal hypoxia-inducible factor-2alpha, but not hypoxia, early in the progression of diabetes in the rat. Exp. Eye Res. 2011, 93:437-441.
45. Yadav A.S., Harris N.R. Effect of tempol on diabetes-induced decreases in retinal blood flow in the mouse. Curr. Eye. Res. 2011, 36:456-461.
46. Yam J.C., Kwok A.K. Update on the treatment of diabetic retinopathy. Hong. Kong. Med. J. 2007, 13:46-60.
47. Yamazaki H., Okazaki M., Takeda R., Haji A. Hypercapnic and hypoxic ventilatory responses in long-term streptozotocin-diabetic rats during conscious and pentobarbital-induced anesthetic states. Life. Sci. 2002, 72:79-89.
48. Zhang W., Ito Y., Berlin E., Roberts R., Berkowitz B.A. Role of hypoxia during normal retinal vessel development and in experimental retinopathy of prematurity. Invest. Ophthalmol. Vis. Sci. 2003, 44:3119-3123.
49. Zhang J., Wu Y., Jin Y., Ji F., Sinclair S.H., Luo Y., Xu G., Lu L., Dai W., Yanoff M., Li W., Xu G.T. Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes. Invest. Ophthalmol. Vis. Sci. 2008, 49:732-742.
50. Zhang Y., Wang Q., Zhang J., Lei X., Xu G.T., Ye W. Protection of exendin-4 analogue in early experimental diabetic retinopathy. Graefes. Arch. Clin. Exp. Ophthalmol. 2009, 247:699-706.